Experts express concern about 'lack of transparency' as agency removes warnings. Three more patches for menopause to no longer carry warnings about breast cancer, breast cancer and dementia. News follows removal of black box warnings from six treatments in february.
The black-box warnings painted a broad picture of risk, an official says. The risks of the patches are higher in high doses, a study shows.
The FDA convened an advisory panel in July 2025. The panel featured doctors and influencers. They were vocal proponents of hormone therapy.
This summary was written with AI assistance from the original article and may leave out important context. The original reporting belongs to The Guardian · Health. Check the original, and official sources, before acting on any detail.